Rising Cases of Pneumonia during the COVID-19 Anticipated to Boost the Global Pneumonia Therapeutics Market

Rising Cases of Pneumonia during the COVID-19 Anticipated to Boost the Global Pneumonia Therapeutics Market

  • October 13, 2020

New York, USA, Oct. 13, 2020 (GLOBE NEWSWIRE) — The latest research report on the global pneumonia therapeutics market by Research Dive reflects the influence of COVID-19 pandemic on the present and forthcoming growth of the global market. This report is a professional and comprehensive research formulated by specialists by evaluating top driving factors, major regional market situations, opportunities & future scope, and trends & developments in the market during the COVID-19 catastrophe.

Highlights of the Report

  • As per the previous report, the global pneumonia therapeutic market was expected to grow at a CAGR of 7.8% during the forecast period.
  • The real-time CAGR has been recorded at 8.2% in a new analysis.
  • The market was estimated to reach $1,783.1 million in 2020 as per the pre-pandemic analysis.
  • The real-time (2020) market size has reached a revenue of $1,817.1 million.

Request for Sample Report of the COVID-19 Impact on Pneumonia Therapeutics Market at: https://www.researchdive.com/download-sample/357

Factors Accelerating the Growth of the Market

The primary factor behind the growth of the global pneumonia therapeutics market is obviously the increasing transmission of the highly infectious and fatal virus. Pneumonia being the most prevalent symptom of COVID-19, the demand for pneumonia therapeutics has been increased.

Current COVID-19 Impacted Scenario of the Market

The leading players of the market are focused on developing new, innovative strategies to sustain the market growth. For instance, BioAegis therapeutics has recently received approval to proceed with phase 2 trial of its gelsolin COVID-19 Treatment. Gelsolin is a key component of the body’s immune system. BioAegis is in a unique position to deliver therapeutics that have the potential to disrupt the course of the cytokine storm created by COVID-19.

Future Scope of the Pneumonia Therapeutics Market

According to the report, the global pneumonia therapeutics market is projected to maintain a sustainable growth post the pandemic. New entrants and leading players are expected to bring in some newer innovative advances and rewarding opportunities for the market in next few years. The report also summarizes other important aspects of the key players including financial performance, product portfolio, SWOT analysis, and recent strategic moves and developments.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/357

Regional Breakdown of the Market

Depending on region, the pneumonia therapeutics market can be further classified into North America, Europe, Asia-Pacific and LAMEA. North America region market was accounted for $581.6 million in 2019 and is predicted to grow with a CAGR of 7.2% in the forecast period. Increasing cases of geriatric population and presence of large number of healthcare institution is predicted to drive the region market in the forecast period.

Top Companies Leading the Pneumonia Therapeutics Market

The major key players in the market are –

  1. Mylan
  2. Novartis Lupin Pharmaceuticals
  3. GlaxoSmithKline
  4. Cipla
  5. Abbott
  6. Sanofi
  7. Merck
  8. Bayer
  9. Allergan

The report summarizes various aspects of all these prominent players including financial performance, recent strategic moves & developments, product portfolio, and SWOT analysis. Quick Download Top Companies Development Strategies Summary Report

Research Dive also offers Custom Research services providing focused, comprehensive and tailored research.

View out Trending Reports with the Impact of COVID-19: https://www.researchdive.com/covid-19-insights

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York NY 10005
(P) +91-(788)-802-9103 (India)
+1-(917)-444-1262 (US)
Toll Free: 1-888-961-4454
E-mail: support@researchdive.com
Website: https://www.researchdive.com
Blog:  https://www.researchdive.com/blog/ 
LinkedIn: https://www.linkedin.com/company/research-dive/ 
Twitter: https://twitter.com/ResearchDive  
Facebook: https://www.facebook.com/Research-Dive-1385542314927521

Citrus Bioflavonoids Market projected to exceed $1.3 billion by 2026, Says Global Market Insights Inc.

Citrus Bioflavonoids Market projected to exceed $1.3 billion by 2026, Says Global Market Insights Inc.

  • September 24, 2020

Selbyville, Delaware, Sept. 24, 2020 (GLOBE NEWSWIRE) — Based on Global Market Insights Inc., report, the global Citrus Bioflavonoids Market size was estimated at $800 million in 2019 and is slated to surpass $1.3 billion by 2026, registering a CAGR of 7.5% from 2020 to 2026. The report provides an in-depth analysis of the key investment avenues, drivers and opportunities, key winning strategies, wavering industry trends, competitive scenarios, and market estimations as well as size.

Increasing adoption of citrus bioflavonoids obtained from lime and lemons is expected to gain traction in the next few years owing to its ease of availability, availability in abundance, and improved health benefits obtained due to the combination of vitamin C and bioflavonoids. Also, it is available in both tablet and powder form, facilitating ease of consumption. Besides, lemons and lime boost the immune system supports digestive system health helps in iron absorption, and promote skin health.  

The increasing applications of hesperidin in treating blood vessel conditions such as hemorrhoids, varicose veins, poor circulation and lymphedema, a condition involving fluid retention that can be a complication of breast cancer surgery is likely to raise the citrus bioflavonoids market share.

Request for Sample Report: https://www.gminsights.com/request-sample/detail/4827

Conventional products dominated the market with a value of over USD 700 Million in 2019. However, increasing consumer preference towards the consumption of products with natural and organic ingredients is likely to raise the share of organic citrus bioflavonoids in the years to come. The growing trend of leading a healthy lifestyle may attract consumer attention towards organic products in the next few years. 

The antioxidant property of citrus bioflavonoids prevents the formation of free radicals which prevents aging and wrinkle formation on skin, thus promoting its use in cosmetic and personal care products. The increasing trend of use of cosmetic preparations made from natural ingredients is likely to drive the citrus bioflavonoids market growth. Also, the fine texture and palatability of the products may raise its demand from animal feed application.  

Some major findings of the citrus bioflavonoids market report include:

  1. Citrus bioflavonoids obtained from orange, tangarines, mandarins is expected to dominate the market owing to its increased cultivation in different regions of the world coupled with its health benefits such as lowering blood sugar and controlling lipid profile and cholesterol levels.
  2. The Orange, tangarines, mandarins segment is expected to exceed USD 800 Million over the forecast period.
  3. The lemons and lime segment is expected to witness considerable growth owing to its easy availability and health benefits of citrus bioflavonoids along with vitamin C.
  4. The lemons and lime segment is expected to grow at a CAGR of 8.0% throughout the forecast period.
  5. Stringent regulations by the U.S. FDA (Food and Drug Administration) regarding the ingredients used in citrus bioflavonoids is likely to pose challenges to the use of the product in pharmaceutical and dietary supplements.
  6. Narirutin and Diosmin products are expected to grow at a CAGR of 5.5% and 5.3% respectively over the assessment period.

Asia Pacific is likely to witness healthy growth owing to increasing consumer awareness regarding the need for leading a healthy dietary lifestyle coupled with the increasing use of cosmetic products made from natural ingredients in an attempt to look more presentable. Additionally, the rapidly growing animal husbandry occupation in different countries of Asia Pacific may create a rising demand for animal feed, thus boosting the growth of citrus bioflavonoids market.

Request for customization of this report: https://www.gminsights.com/roc/4827

Industry players are engaged in acquiring firms and boosting production capacity to meet growing demands from cosmetics and personal care applications which should boost growth of citrus bioflavonoids market. Manufacturers are rapidly investing in R&D and experimenting with various formulations to provide better quality products which should contribute to citrus bioflavonoids market growth.

Major players in the citrus bioflavonoids industry include Organika Health Products Inc., Nature LLC, Solgar Inc., Freeda Vitamins Inc., NOW Foods, Natural Factors Inc., Country Life, Cayman Chemical Company, Merck KGaA , Nans Products, Nacalai Tesque Inc., BOC Sciences, Santa Cruz Biotechnology, Inc., Hunan Sunfull Bio-tech Co., Ltd., J&K Scientific Ltd., Hunan Yuantong Pharmaceutical Co., Ltd., Yaan Times Biotech, Destilaciones Bordas Chinchurreta S.A., Yakult Honsha Co., Ltd and MORRE-TEC Industries.

About Global Market Insights, Inc.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider. Offering syndicated and custom research reports, growth consulting and business intelligence services, Global Market Insights, Inc. aims to help clients with penetrative insights and actionable market data that aid in strategic decision making.

GMIPulse, our business analytics platform offers an online, interactive option of exploring our proprietary industry research data in an easy-to-use and dynamic manner. Clients get to explore market intelligence across 11 top level categories and hundreds of industry segments within them, covering regional, company level and cross-sectional statistics that make our offering a stand-out for decision makers.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com 
Web: https://www.gminsights.com

Global Vaccines Market 2020 Development Status, Competition Analysis, Type and Application 2025 – The Daily Chronicle

  • September 13, 2020

Vaccines Industry 2020 Global Market research report studies the latest Vaccines industry aspects market size, share, trends, Opportunities and Strategies To Boost Growth, business overview, revenue, demand, marketplace expanding, technological innovations, recent development, and Vaccines industry scenario during the forecast period (2020-2025).

Download Premium Sample of the Report: https://industrystatsreport.com/Request/Sample?ResearchPostId=285&RequestType=Sample

Vaccines Market: Rising burden of several infectious and non-infectious diseases, increasing government and non government support for vaccine development, and increasing Research and Underdevelopment likely to augment the growth of Global Vaccine Market.

Scope of Global Vaccine Market Reports –
A vaccine is a biological preparationwhich is administered to produceactive acquired immunity for particular disease and it is prepared from weakened or killed forms of the microorganism such as bacteria & viruses or from its toxins or proteins. Administration of vaccines is called as “Vaccination” which aids to increase the immune response against a specific pathogen.Human body has natural ability to learn about eliminating all sorts of germs or microbes that cause diseases. Vaccine uses that ability of the body to enable it to defend itself from those microorganisms which have attacked it earlier. Usually vaccines are administered through injections, orally and sprayed into the nose.Vaccines can be divides into many types such as inactivated vaccines, attenuated vaccines, toxoid, and conjugate. Cholera, influenza, hepatitis A, polio, and rabies vaccines are inactivated vaccines.

The Global Vaccines Market is categorized on the basis of the various diseases that can either be prevented or treated by using vaccines. Various diseases that are treated using H1N1 vaccines include influenza, meningococcal, cervical cancer, pneumococcal, hepatitis, measles, mumps, rubella, etc.The demand for vaccinations has increased over the last few years, due to the rising incidence of viral and bacterial infectious diseases. Vaccinations are essentially administered to people of different age groups, which build up their immune system throughout lifespan and gives protection against different types of infectious diseases.Vaccine technology is procedure to observe a revolution. As a more understanding of the human immune system’s protective antibody and cell-based responses to foreign antigens will causes the development of advanced diagnostics and improvement of therapeutic applications. As further governments across the

World identify the welfare of mass vaccination, the trend of vaccines providing healthcare solutions on a large scale will continue. Certain increasing demand worldwide and currently-unmet needs, the Global Vaccination Market has substantial potential for technological novelty and revenue growth.Vaccines are a supreme tool for effective healthcare management due to their low cost and prolonged protection. The increasing popularity of pediatric, travel, addiction and pediatric combination vaccines the newly developed vaccines that are safer and more effective, better public awareness, technological advancements in molecular genetics area and the adoption of novel vaccine delivery mechanisms are chiefly driving the growth of the global vaccination market. Moreover, the production of new therapeutic and prophylactic vaccines for fighting HIV/AIDS, congenital abnormalities, malaria and cancer, as well as other deadly diseases is also boost the Global Vaccine Market growth.

Immunization presently prevents an estimated 2 to 3 million deaths per year. Moreover additional 1.5 million deaths could be avoided due to enhanced global vaccination coverage. Increasing acceptance of new and underused vaccines will highly strengthen its global usage in the upcoming future.

Global Vaccines Market has been segmented on the basis of Technology, Indication, End User and Geography. On the basis of TechnologyGlobal Vaccines Market is classified into Conjugate Vaccines, Live Attenuated Vaccines,Inactivated Vaccines Toxoid Vaccines, Recombinant Vaccines and Others. On the basis of IndicationGlobal Vaccines Market is segmented into Influenza, Pneumococcal Disease, Meningococcal Disease, Human Papilloma Virus, Rotavirus, Varicella, Diphtheria-Pertussis-Tetanus (DTP), Polio, Hepatitis, Measles-Mumps- Rubella (MMR) and others. On the basis of End User Global Vaccines Market is classified into Pediatric Vaccines, Adult Vaccines, Traveler Vaccines and Others.

The regions covered in Global Vaccines Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Vaccines Market Reports –
Global Vaccines Market reports cover prominent players like Glaxo Smith Kline plc, Pfizer Inc., Merck & Co. Inc., Sanofi, CSL Limited, Emergent BioSolutions Inc. , Johnson & Johnson, Medimmune, LLC, AstellasPharma Inc., Serum Institute of India, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company Limited, Bavarian Nordic,Panacea Biotech, Protein Sciences Corporation, AstraZeneca, Abbott, Bristol-Myers Squibb,Novavax Inc., Gritstone Oncology, PaxVax Corporation.,Bharat Biotech., VBI Vaccines Inc.,Dynavax Technologies Corporation, Immunomic Therapeutics, Inc., Gamma Vaccines Pty Limited, Sinovac Biotech Ltd., Prokarium, and ImmunoBiology Ltd.,Janssen Pharmaceutical Company,Takeda Pharmaceuticals Company Ltd., Valeant Pharmaceuticals International, Inc., China National Biotech, Tiantan, Hualan, Kangtai,Hissen andJintan.

Global Vaccines Market Dynamics –
The rise in acceptance of pediatrics, travel, addiction, and pediatric combination vaccines also recently developed vaccines that are safer and more effective, better, public awareness, technological advancements in molecular genetics area and the acceptance of new vaccine delivery mechanisms are mainly driving the growth of the Global Vaccination Market. Rise inincidence of infectious diseases such as influenza, malaria, pneumonia, measles, meningococcal meningitis, dengue, HIV, hepatitis, and diphtheria is somewhat high, as well asGovernment initiatives for expanding vaccination coverage are likely to boost the demand for vaccines globally. The Government of Asian country launched the ‘Pan-India campaign for contagious disease-Rubella Vaccination’ in February 2017 to safeguard kids from chief childhood diseases like three-day measles and Measles.This nationwide vaccination campaign aims to administer measles-rubella vaccine (MR-VAC) to children aged between nine months and 15 years and increasing investments by companies are driving the vaccine market.Excessive cost related with storage and transportation of vaccines will restrain the Global Vaccine Market growth. Limited reimbursement coverage and stringent government regulations for the approval of products will further hamper the Global Vaccine Market expansion over the coming years. Crucial problems in the Global Vaccine Market now a days are product safety, supply shortages, use of vaccines to prevent infectious diseases and discoveries in vaccine delivery systems.

Global Vaccine Market Regional Analysis –
Geographically, North America is expected to dominate the market in terms of revenues, due to continuous research funding for vaccine development in the region, increasing investments by government organizations and companies to promote immunization as well as develop new vaccines. Also because of launch of recent vaccine by pharmaceutical firms is predicted to assist the region maintain its dominance throughout the forecast amount. Introduction of recent product is predicted to enhance the demand for the vaccines within the region therefore serving to it stay the biggest marketplace for this product globally. For instance, the Healthy People 2020 aims for immunization to prevent and treat infectious diseases.
Europe is likely to hold the second largest share of this market due to availability of funding and venture capital investments for the development of new vaccines and increasing government initiatives driven market growth in this region.

Germany will grow at a significant rate over the coming years due to increasing government initiatives to provide medical advice for the vaccinating children. Increasing prevalence of infectious diseases and focused product development will boost the Global Vaccine Market.

Asia Pacific can see substantial growth over the forecast amount because of increasing awareness for interference of diseases like TB (TB), Japanese cephalitis, protozoal infection and dengue fever still as introduction of re-emerging or newer diseases like infection with severe acute metabolic process syndrome (SARS), respiratory disease A (H5N1) virus (avian flu) and Chikungunya. Additionally rising financial condition and growing adoption for advanced technology ought to accelerate regional revenue share.

Key Benefits for Global Vaccine Market Reports –
Global Vaccine Market report covers in depth historical and forecast analysis.
Global Vaccine Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global Vaccine Market report helps to identify opportunities in market place.
Global Vaccine Market report covers extensive analysis of emerging trends and competitive landscape.

Vaccine Market Segmentation

By Technology
Conjugate Vaccines
Inactivated Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Others

By Indication
Influenza
Pneumococcal Disease
Meningococcal Disease
Human Papilloma Virus
Rotavirus
Varicella
Diphtheria-Pertussis-Tetanus (DTP)
Polio
Hepatitis
Measles-Mumps- Rubella (MMR)
Others

By End User
Pediatric Vaccines
Adult Vaccines
Traveller Vaccines
Others

Regional & Country Analysis
North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa.

Request Customization of the Report: https://industrystatsreport.com/Request/Sample?ResearchPostId=285&RequestType=Methodology

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Vaccines Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

  1. Market Dynamics
    2.1 Market Drivers
    2.2 Market Constraints and Challenges
    2.3 Emerging Market Trends
    2.4 Impact of COVID-19
    2.4.1 Short-term Impact
    2.4.2 Long-term Impact

3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 Expansion Plans

5 Analysis of Leading Companies
5.1 Company 1
5.1.1 Company 1 Company Profile
5.1.2 Company 1 Business Overview
5.1.3 Company 1 Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Company 1 Vaccines Products Introduction

5.2 Company 2
5.2.1 Company 2 Company Profile
5.2.2 Company 2 Business Overview
5.2.3 Company 2 Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Company 2 Vaccines Products Introduction

5.3 Company 3
5.3.1 Company 3 Company Profile
5.3.2 Company 3 Business Overview
5.3.3 Company 3 Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Company 3 Vaccines Products Introduction

5.4 Company 4
5.4.1 Company 4 Company Profile
5.4.2 Company 4 Business Overview
5.4.3 Company 4 Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Company 4 Vaccines Products Introduction
……………………………………………………………

6 Market Analysis and Forecast, By Product Types
6.1 Global Vaccines Sales, Revenue and Market Share by Types (2015-2020)
6.2 Global Vaccines Market Forecast by Types (2020-2026)
6.3 Global Vaccines Sales, Price and Growth Rate by Types (2015-2020)
6.4 Global Vaccines Market Revenue and Sales Forecast, by Types (2020-2026)

7 Market Analysis and Forecast, By Applications
7.1 Global Vaccines Sales, Revenue and Market Share by Applications (2015-2020)
7.2 Global Vaccines Market Forecast by Applications (2020-2026)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.4 Global Vaccines Market Revenue and Sales Forecast, by Applications (2020-2026)

8 Market Analysis and Forecast, By Regions
8.1 Global Vaccines Sales by Regions (2015-2020)
8.2 Global Vaccines Market Revenue by Regions (2015-2020)
8.3 Global Vaccines Market Forecast by Regions (2020-2026)
Continued……………….

Read More: https://industrystatsreport.com/Lifesciences-and-Healthcare/Vaccines-Market/Summary

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at [email protected]

Blog: https://businessstatsnews.com   

Blog: http://www.dailyindustrywatch.com  

Blog: https://marketsize.biz   

Blog: https://technologyindustrynews.com

Blog: https://marketstatsreport.com  

Blog: https://tcbiznews.com/

img

Superfood Powders Market Anticipated to Cross $7.11 Billion By 2027 | Grand View Research, Inc

  • September 10, 2020

(MENAFN – GetNews) According to report published by Grand View Research, the global superfood powders market size was valued at USD 4.32 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 6.4% from 2020 to 2027.

The global superfoods powders market is set to register a CAGR of 6.4% during the forecast period. Superfood powders are rich in nutrients and the products offer numerous health benefits that range from detoxifying the body naturally and imploring the immune system, to boosting energy levels and sexual health. They are suitable for improving nutrient quantity in baked goods, smoothies, yogurt, and lattes, which are consumed on a daily basis. 

Consumers are comprehensively aware of their well-being and health by embracing a balanced set of dietary intake. In addition, people are increasingly seeking effective food products that provide functional boost, whether it is a beverage, snack, or on-the-go meal.

North America held the largest market share of more than 40.0% in 2019. High consumption in countries, such as the U.S. and Canada, is anticipated to boost market growth during the forecast period. Furthermore, several major producers are based in the region. Over the past few years, consumers have been adding the product in numerous food and drink items in order to obtain the health benefits of the product.

Browse Details of Report, Please Visit @ [To enable links contact MENAFN]



Covid-19 Effect:

According to an August 2020 FMI report, the COVID-19 pandemic has prompted the superfoods powder boom. The FMI study insight revealed that showed approximately 65% of customers are actively seeking to buy food & beverages enriched with supplements such as hemp, maca, matcha, and moringa with 25% specifically buying ‘superfoods. Furthermore, firms in the US immunity-oriented products have witnessed a more than 40% surge year on year in multivitamin sales. Against the backdrop of the COVID-19 pandemic, public interest in consuming healthy foods is pushing the demand for ‘superfood powders, despite the ongoing scientific debate about the claimed health benefits.  Products that contain superfoods powders as an active ingredient are now likely to have broken out of their conventional domain at healthy food stores to capture the opportunity opened up by prevalent fear of the virus and health-conscious behaviors among people. The burgeoning shopper trend is anticipated to provide more growth opportunities for South and East Asian countries.

Key Takeaways from the report:

  • The organic product segment is expected to witness the fastest growth during forecast years with a CAGR of 6.7% from 2020 to 2027. Growing demand for organic products among the health-conscious consumers is expected to fuel the segment growth over the next few years

  • The online distribution channel is expected to witness the fastest growth during forecast years with a CAGR of 7.5% from 2020 to 2027. An increasing number of companies launching  websites is boosting the online sales of the product

  • Asia Pacific is expected to witness the fastest growth during forecast years with a CAGR of 7.4% from 2020 to 2027. The rising importance of health wellness among millennials in developing countries, including China and India, is expected to remain a favorable factor for the industry growth

  • North America dominated the market and accounted for over 40.0% share of the global revenue in 2019. Wide penetration of the product in the U.S. and Canada is expected to be a key reason behind the growth.

  • Offline distribution channel accounted for a major revenue share in 2019. Superfoods are being progressively sold in hypermarkets, convenience stores, supermarkets, and pharmacies. A significant number of consumers are buying products from supermarket stores to gain a shopping experience.
  • Conventional products held for more than 50.0% of the global revenue share in 2019.  The segment is witnessing huge demand with the launch of wonder foods labeled as ‘super grain or ‘superfruit.



Request For Free Sample Report @ [To enable links contact MENAFN]

Major Players:

  • Sunfood
  • Unilever
  • Superlife Co. Pte Ltd.
  • Your Super
  • NAVITAS ORGANICS
  • ALOHA
  • ORGAN IC d.o.o.
  • Suncore Foods Inc.
  • Supernutrients
  • NATURE SUPERFOODS

Have  Inquiry before buying  about this report, our team of analyst will be glad to help!

Grand View Research has segmented the global superfood powders market on the basis of product, distribution channel, and region:

Superfood Powders Product Outlook (Revenue, USD Million, 2016 – 2027)

Superfood Powders Distribution Channel Outlook (Revenue, USD Million, 2016 – 2027)

Superfood Powders Regional Outlook (Revenue, USD Million, 2016 – 2027)

  • North America
  • Europe
  • Asia Pacific
  • Central & South America
  • Middle East & Africa

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address: 201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: [To enable links contact MENAFN]


Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Sepsis Diagnostics Market Boosting The Growth, Dynamics Trends, Efficiencies Forecast 2026 – The Daily Chronicle

Sepsis Diagnostics Market Boosting The Growth, Dynamics Trends, Efficiencies Forecast 2026 – The Daily Chronicle

  • September 8, 2020

A persuasive Sepsis Diagnostics Market report can be explored more specifically in terms of breakdown of data by manufacturers, region, type, application, market status, market share, growth rate, future trends, market drivers, opportunities, challenges, emerging trends, risks and entry barriers, sales channels & distributors. The data and information have been derived from the reliable sources and include websites, annual reports of the companies, journals, and mergers which have been again checked & validated by the market experts. The estimations of CAGR values are also provided in this wide ranging Sepsis Diagnostics Market report which helps businesses in deciding upon the investment value over the time period.

Get Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-sepsis-diagnostics-market&rp

This Sepsis Diagnostics Market report takes into account the conception of business goals and requirements to bridge the gap by delivering the most proper and suitable solutions. The competitive analysis is also performed in this report which covers strategic profiling of key market players, their core competencies & competitive landscape of the market which aids businesses characterize their individual strategies. In this market document, market drivers and market restraints are studied carefully along with the analysis of market structure. To provide an absolute overview of the Healthcare industry, Sepsis Diagnostics Market analysis report covers various aspects of market analysis, product definition, market segmentation, key developments & the existing vendor landscape.

 

Market Analysis: Global Sepsis Diagnostics Market 

Global Sepsis Diagnostics Market is expected to rise from its initial estimated value of USD 439.60 million in 2018 to an estimated value of USD 875.92 million by 2026, registering a CAGR of 9.0% in the forecast period of 2019-2026. This rise in market value can be attributed to the Increase in prevalence of sepsis.

Key Market Competitors: Global Sepsis Diagnostics Market 

Few of the major competitors currently working in the sepsis diagnostics market are bioMérieux SA (France), BD, Thermo Fisher Scientific Inc. (US), Abbott (US), Danaher (US), Luminex Corporation (US), Bruker (US), AXIS SHIELD (UK), Sandstone Diagnostics, Inc., Inflammatix, Inc., Questex LLC, Mayo Foundation for Medical Education and Research (MFMER), Spectral Medical Inc., DNA Electronics, T2 Biosystems, Inc., F6S Network Limited., EKF, F. Hoffmann-La Roche Ltd(Switzerland), CytoSorbents (US), Mitsubishi Chemical Europe, and among others.

Get Full TOC, Tables and Figures of Market Report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-sepsis-diagnostics-market&rp

Market Definition: Global Sepsis Diagnostics Market 

Sepsis is fatal conditions arise due to the weak immune system to its own tissues and organs. It occurs due to chronic illness, liver or kidney diseases, cancer or severe wounds. Sepsis is one of the common causes of death in hospitalized patients. Increasing prevalence in hospital-acquired infections which must be diagnosed boosts the growth of market.

In the U.S. alone, around 1,000,000 death cases account to sepsis caused to the hospitalized patients. Moreover, development of biomarkers used in the clinical assays possessing specificity has driven the business growth significantly. This significant number is expected to act as a driver to the market growth.

Segmentation: Global Sepsis Diagnostics Market 

Sepsis Diagnostics Market : By Product

  • Instruments
  • Blood Culture Media
  • Assay Kits & Reagents
  • Software

Sepsis Diagnostics Market : By Technology

  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Flow Cytometry
  • Biomarkers
  • Microfluidics

Sepsis Diagnostics Market : By Method

  • Conventional Diagnostics,
  • Automated Diagnostics

Sepsis Diagnostics Market : By Usability

  • Laboratory Testing
  • Point-Of-Care Testing

Sepsis Diagnostics Market : By Pathogen

  • Bacterial Sepsis
  • Fungal Sepsis

Sepsis Diagnostics Market : By End User

  • Hospitals
  • Pathology & Reference Laboratories

Sepsis Diagnostics Market : By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

Key Developments in the Sepsis Diagnostics Market :

  • In April 2018, Curetis NV announced that their collabo rated partner acumen research laboratories pte. Ltd received approval for Unyvero BCU Cartridge for bloodstream infection in Singapore.
  • In 2016, BioFire Diagnostics, LLC, the molecular biology counterpart of bioMérieux received U.S. FDA clearance for FilmArray Torch for use with the FilmArray Blood Culture Identification (BCID) Panel.

Sepsis Diagnostics Market Drivers :

  • Rise in cases of hospital-acquired infections, this act as a driver to the market.
  • Neonatal and geriatric population is more affective to sepsis, this act as a driver to the market.

Sepsis Diagnostics Market Restraints :

  • Absence of standard protocol this significant act as restraints to the market.
  • Lack of skilled physicians, this significant act as restraints to the market.

Reasons to Purchase this Report :

  • Current and future of global sepsis diagnostics market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-sepsis-diagnostics-market&rp

About Data Bridge Market Research :

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us :

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Mail: [email protected]

Vaccine Adjuvants Market Size Forecast to Reach $1.67 Billion by 2025

Vaccine Adjuvants Market Size Forecast to Reach $1.67 Billion by 2025 · Wall Street Call

  • September 7, 2020

Sep 7, 2020 3:07 PM ET

iCrowd Newswire – Sep 7, 2020

Vaccine Adjuvants Market size is forecast to reach $1.67 billion by 2025, growing at a CAGR of 8.24% during the forecast period 2020-2025. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. Aluminum adjuvants are used in vaccines such as hepatitis A, hepatitis B, diphtheria and tetanus-containing vaccines. Protection via donated antibodies is short-lived, whereas protection via the tetanus shot lasts 10 years or more. Immunologic adjuvants are often used to modify or augment the effects of a vaccine by stimulating the immune system to respond to the vaccine more vigorously, and thus providing increased immunity to a particular disease. Immunostimulants and adjuvants can be administered before, with, or after vaccines to amplify the specific immune response generating elevations of circulating antibody titers and numbers of plaque-forming cells. Rapidly increasing incidences of various diseases among the masses, increasing demand for improved vaccine treatments, increasing R&D activities and investments, and government investments for providing vaccine dosage to the people are driving the market growth in recent years. In addition, urgent need for vaccine development of novel coronavirus (COVID-19) and major product launches of key players like Seppic and Seqirus are other factors driving the growth of the market.

Product Type – Segment Analysis

Particulate Adjuvants held the largest share in the product type segment of Vaccine Adjuvants Market in 2019 and is estimated to grow at a CAGR of 7.5% during the forecast period 2020-2025. Particulate adjuvants have witnessed a surge in their market share, owing to their efficient treatments and several advantages. These include passive targeting to the antigen-presenting cells within the immune system, protection against adjuvant degradation, and ability for sustained antigen release. Aluminum salts are by far the most commonly used adjuvants in vaccines. There are only two aluminium salts which are used in clinically-approved vaccines, Alhydrogel and AdjuPhos, while the novel aluminium adjuvant used in Gardasil is a sulphated version of the latter. Increasing popularity of aluminium adjuvants is attributed to their quicker clinical approvals, better potential clinical services in its history and enhanced delivery of antigen to immune system. These factors have aided the market growth in the past few years on a large scale. Combination Adjuvants held the second largest share in 2019. With the help of combined strategies, the vaccine becomes capable of provoking an abundant and effective immunization to compete against antigens with minimal/no adverse effects on recipients. Pathogen Components is set to be the fastest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025, owing to increasing R&D activities and newer product developments by market companies.

Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=510721

Report Price: $ 5900 (Single User License)

Disease Type – Segment Analysis

Infectious Diseases hold the major share in the disease type segment of Vaccine Adjuvants Market in 2019. This growth is primarily driven by the large number of incidences every year. According to the World Health Organization (WHO), nearly 50,000 men, women and children are dying every day from infectious diseases. Diseases like malaria, dengue, influenza and hepatitis A, B & C are taking lives every year on a high rate. Secondary factors helping the growth include growing mass awareness about treatment by vaccines and presence of advanced pipeline products for vaccine adjuvants for treatment of infectious diseases. Cancer is forecast to grow at the fastest rate with the highest CAGR during the forecast period 2020-2025, owing to increasing cancer treatments across the world and major R&D activities by market players on cancer targeted drugs and therapies.

Geography – Segment Analysis

North America dominates the geography segment of Vaccine Adjuvants Market with a share of more than 41.55% in 2019, followed by Europe. Rising incidence of serious epidemic diseases, demand for vaccine of novel COVID-19 amidst the widespread fatalities, high healthcare expenditure by the government and presence of key market players in this region have helped in the growth of Vaccine Adjuvants Market infrastructure. Europe held the second place in the geography segment share of the market, owing to presence of a well-developed healthcare infrastructure, growing prevalence of epidemics and presence of key market players in this region.

However, Asia-Pacific is estimated to grow at the fastest rate at a higher CAGR during the forecast period 2020-2025. This is owing to growing technological innovations in the healthcare sector, increasing awareness about vaccines, and increasing disposable income of the population.

Drivers – Vaccine Adjuvants Market

Growing prevalence of infectious and chronic diseases

Infectious diseases are a leading cause of death worldwide, particularly in low income countries, especially in young children. Three infectious diseases were ranked in the top ten causes of death worldwide in 2016 by the World Health Organization. They are lower respiratory infections (3.0 million deaths), diarrheal diseases (1.4 million deaths), and tuberculosis (1.3 million deaths). Another infectious disease, malaria, accounts for a top cause of death in low income countries. On the other hand, chronic diseases has been rapidly increasing worldwide. It is estimated that by 2025, chronic diseases is set to contribute approximately to 60% of the 56.5 million total reported deaths in the world and approximately 46% of the global burden of disease. This has resulted in widespread demand for vaccines for proper treatment in less time. In recent months, there is a huge demand of Vaccine Adjuvants for COVID-19, which has further aided the market growth.

Increasing government expenditure for vaccine awareness programs

Ministries of Health in many countries are continually confronted with the challenge of protecting resources for essential programs from the vagaries of the domestic budgeting process and the volatility in external donor financing. Adequate and reliable health financing is one of several essential elements required to ensure continuity in service delivery, and to fund continuous increases in coverage, quality and access to health services. This is all the more important for disease specific preventive programs such as immunization. The health benefits of vaccination has helped people and government become aware and invest in development of vaccine products. This has fuelled the market growth by a large scale. R&D activities for finding vaccines for proper treatment of COVID-19 is projected to further drive the Infusion Market growth during the forecast period 2020-2025.

Talk to one of our sales representative about the full report by providing your details in the link below:

https://www.industryarc.com/support.php?id=510721

Challenges – Vaccine Adjuvants Market

Higher costs of adjuvant vaccine products and development

Adjuvanted vaccines would be cost-effective at a $1 adjuvant cost (on top of the standard vaccine cost) when the adjuvant efficacy (in overcoming the difference between vaccine response in patients and healthy adults) is greater than or equal to 60% and economically dominant (provides both cost savings and health benefits) when the $1 adjuvant’s efficacy is 100%. In most cases, this is out of the reach of the average patient. This is anticipated to hamper the market growth during the forecast period 2020-2025.

Vaccine Adjuvants Industry Outlook

Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Vaccine Adjuvants Market. In 2019, Vaccine Adjuvants Market share is consolidated by the top players present in the market. Vaccine Adjuvants Market top 10 companies are Brenntag Biosector A/S, Seppic, Seqirus, Agenus, Inc., Novavax, Inc., Invivogen, SPI Pharma, Inc., Avanti Polar Lipids, Inc., MVP Laboratories, Inc. and OZ Biosciences among others.

Acquisitions/Product Launches

In April 2020, Seppic announced the launch of its new product, Montanide™ ISA 78 VG. Montanide™ ISA 78 VG is an innovative alternative to Montanide™ ISA 71 VG and Montanide™ ISA 71R VG. Designed for water-in-oil emulsions, this novel adjuvant is particularly stable and powerful.

In February 2020, Seqirus announced the U.S. FDA approval of its first-ever adjuvanted, cell-based pandemic influenza A (H5N1) Vaccine.

In April 2019, Agenus announced that the first patient was dosed in the clinical trial of its next-generation anti-CTLA-4 antibody (AGEN1181). AGEN1181, a novel ‘Fc engineered’ antibody with potential for enhanced anti-tumor functions, is specifically designed to boost cancer killing immune cells and deplete cells that block the activity of these cancer killing cells.

Key Takeaways

North America dominated the Vaccine Adjuvants Market in the year 2019 owing to increasing demand for improved medical results from vaccines, widespread transmission of coronavirus, growing prevalence of infectious diseases and increasing government investments for improvements in healthcare sector. The Vaccine Adjuvants Market scope for different regions will be provided in the final report.

Growing prevalence of infectious and chronic diseases in the last decade, increasing investments in R&D activities of vaccine, demand for vaccine of novel coronavirus (COVID-19) and increasing government expenditure for vaccine awareness programs have helped in significant growth of Vaccine Adjuvants Market.

Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Vaccine Adjuvants Market report.

Higher costs of adjuvant vaccine products are anticipated to hamper the market growth of the Vaccine Adjuvants Industry.

Related Reports:

A. Vaccines Market

https://www.industryarc.com/Report/17004/vaccines-market.html

B. Adjuvants Market

https://www.industryarc.com/Report/15280/adjuvants-market.html

About IndustryARC : IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.

Also Read:

Contact Information:

Venkat Reddy
Sales Director
Email: [email protected]
Website: https://www.industryarc.com
Phone: (+1) 970-236-3677


iCrowdNewswire

Keywords:    Vaccine Adjuvants Market, Vaccine Adjuvants Market size, Vaccine Adjuvants Market industry, Vaccine Adjuvants Market share, Vaccine Adjuvants top 10 companies, Vaccine Adjuvants Market report, Vaccine Adjuvants Market industry outlook

Insights on the Human Microbiome Immunology Therapeutics Global Market to 2025

Insights on the Human Microbiome Immunology Therapeutics Global Market to 2025

  • September 2, 2020

Dublin, Sept. 02, 2020 (GLOBE NEWSWIRE) — The “Global Human Microbiome Immunology Therapeutics Market & Clinical Trial Insight 2025” clinical trials has been added to ResearchAndMarkets.com’s offering.

The scale and scope of microbiome research activity has now become one of the fastest growing areas in biology. The relevance that it has shown for the welfare of the society and pharmaceutical industry has led to the development of a transdisciplinary environment that is however conducive to innovation with a mission to abolish the limitations in the pharmaceutical industry through excellence in microbiome research, awareness and outreach. Over the years now, gut microbiome is estimated to implicate success for the various immunotherapies.

Microbiome’s role in immunology practices is to transform world-class treatment into the medicine of today and tomorrow. It is highly recognizable that the healthcare issues that mankind is facing today is now bigger than any one solution. The treatment of certain diseases requires multiple options for the treatment and ultimately prevention. Therefore, the amalgamation of two different treatment paradigms i.e. microbiome and immunology are apparently delivering some medical benefits that millions of patients were in need for long period of time. The ways in which microbiome is understood and manipulated to serve the immunological aspects has given great interest to all the researchers.

The essential and usual concept of immunology depicts targeting the immune system of the body to provoke an immune response with huge impact but then the unsuccessful implication of immunology therapies driven treatments led to an exploration of several other basic concepts that could play an important role in boosting the immune system when combined. Looking forward, the microbiome community in the gut represented beneficial patterns with respect to further research. The area of microbiome research and its combination with immunological aspect for the disease treatment has produced a real excitement in the area of medical research and specifically microbiome research.

All over the world, the amalgamation of the two has been well accepted and appreciated by the patients, physicians and the clinicians. Investigation of all the working sides of microbiome and how it plays an important role in boosting the manipulated immune cells have recently started in large numbers as the technology available in the medical field allows to capture it accurately. To facilitate the microbiome and immunology community in order to extract the best and trending opportunities that are stemmed into the microbiome research, the experts from both the relevant disciplines are analyzing it through clinical researches and surveys. Further, the area is getting supported by 86 different clinical trials getting conducted in different countries.

The Global Human Microbiome Immunology Therapeutics Market & Clinical Trial Insight 2025 report summarizes the view of the wider opportunities that are associated microbiome community for the advancement of the scientific information regarding immunology. The science that is related to microbiome has high interdisciplinary and various opportunities that somehow have remained hidden in the medical world. It is believed that the opportunities and all the desirable tangible benefits microbiome is capable of delivering when combined with immunology is large and needs coordinated and constructive approach. The call to the two different sectors i.e. microbiology and immunology is estimated to unlock the potential and promising benefits of microbiome. The approach leading to the extraction of advantages if properly embedded in the microbiome and immunology research, the future benefits will be huge

Report Highlights:

  • Global & Regional Market Insight
  • Global Human Microbiome Immunology Therapeutics Market: >US$ 1 Billion by 2025
  • US Dominates Global Market Landscape: >60% Market Share
  • Comprehensive Information on Ongoing Clinical Trials & Potential Drug Candidates
  • Global Microbiome Modulator Drugs in Clinical Pipeline: >80 Drug in Trials
  • Therapeutic Applications of Microbiome Immunology by Indication
  • Clinical Trial Studies Related to Fecal Microbiota Transplant: > 250 Clinical Trials

Key Topics Covered:

1. Overview of Microbiome
1.1 Introduction to Microbiome
1.2 History & Evolution of Microbiome

2. Role of Microbiome in Human Body

3. Microbiome: Various Forms
3.1 Gut Microbiome
3.2 Lung Microbiome
3.3 Skin Microbiome
3.4 Microbiome in Other Parts of the Body

4. Mechanism of Microbiome Activity
4.1 Nature of Immune Response
4.1.1 Immunosuppressive Activity
4.1.2 Immunostimulatory Activity
4.2 Messengers Involves in Microbiome Mechanism
4.2.1 MAMPs/PAMPs
4.2.2 Microbial Metabolites As Messengers
4.2.3 Host Cytokines As Messengers
4.2.4 Immune Cells As Messengers

5. Technological Requirement for Microbiota
5.1 Technologies Used
5.1.1 iChip
5.1.2 Simulator of the Human Intestinal Microbial Ecosystem (SHIME)
5.1.3 Gut-on-a-Chip System
5.1.4 Colonic Stem Cell Construction
5.2 Harnessing & Engineering the Microbiome
5.2.1 Additive Approaches
5.2.2 Subtractive Approaches

6. Need for Microbiome Immunology

7. Therapeutic Applications of Microbiome Immunology
7.1 Microbiome Therapy
7.2 Precision Medicine
7.3 Drug discovery
7.4 Biomarkers & Therapy Optimization

8. Human Microbiota in Infectious Diseases
8.1 Infection with Clostridium Difficile
8.2 Infection with Helicobacter Pylori
8.3 Bacterial Vaginosis
8.4 Infection with HIV

9. The Human Microbiota & Liver Diseases
9.1 Non-Alcoholic Fatty Liver Disease (NAFLD)
9.2 Alcoholic Liver Diseases (ALD)
9.3 Liver Fibrosis & Cirrhosis

10. The Human Microbiota & Metabolic Disorders
10.1 Obesity
10.2 Type 2 Diabetes

11. The Human Microbiota & Other Diseases
11.1 Microbiota & Allergic Diseases
11.2 Microbiota & Psychiatric Diseases

12. Microbiome in Immuno Oncology
12.1 Role of Microbiome in Immuno Oncology
12.2 Microbiome Mechanism in Oncogenesis & Tumor Suppression

13. Microbiome Application by Cancer Types
13.1 Gastric Cancer
13.2 Colorectal Cancer
13.3 Esophageal Cancer
13.4 Hepatocellular Carcinoma
13.5 Melanoma
13.6 Solid Tumors

14. Industrial Approaches of Microbiome Therapy in Oncology
14.1 Bacterial Approaches
14.1.1 Fecal Microbiota Transplantation (FMT)
14.1.2 Synthetic Bacteria
14.1.3 Microbial Culture
14.2 Microbiome as Vaccine
14.3 Microbiome as Small Molecules
14.4 Microbiome Therapy using Phage Virus

15. Global Human Microbiome Market Analysis
15.1 Overview
15.2 Human Microbiome Market Segmentation
15.2.1 Regional Segmentation
15.2.2 Disease Based Segmentation
15.2.3 Segmentation by Application

16. Clinical Pipeline of Microbiome Based Therapy
16.1 Microbiome Modulators in Clinical Trial
16.2 Cancer Related Clinical Trials
16.2.1 Preclinical & Discovery Phase
16.2.2 Active Clinical Trials
16.3 Clinical Trial Related To FMT
16.3.1 Clinical Trial for Recurrent C. difficile
16.3.2 Clinical Trial for Inflammatory Bowel Disease (IBD)
16.3.3 Other FMT Related Clinical Trials

17. Global Microbiome Modulators Clinical Pipeline By Company, Indication & Phase
17.1 Research
17.2 Preclinical
17.3 Clinical
17.4 Phase-I
17.5 Phase-I/II
17.6 Phase-II
17.7 Phase-II/III
17.8 Phase-III

18. Marketed Microbiome Modulators Clinical Insight
18.1 Sodium Oligomannurarate – Shanghai Green Valley Pharmaceutical
18.2 Miya-BM

19. Global Microbiome Immunology Therapeutics Market Growth Drivers

20. Microbiome Technology – Investments, Acquisitions & Collaborations by Leading Microbiome Companies

21. Blockades in the Microbiome Immunology Market
21.1 Stable Engraftment
21.2 Development of Clinically Relevant Sensors
21.3 Robustness and Evolutionary Stability of Genetic Circuits
21.4 Regulation, Safety and Biocontainment

22. Global Microbiome Immunology Market Future Panorama

23. Competitive Landscape
23.1 4D Pharma
23.2 AbbVie
23.3 AstraZeneca plc
23.4 Biocodex
23.5 Bristol Mayer Squibb
23.6 Corebiome/Diversigen
23.7 Elogi Bioscience
23.8 Enterome
23.9 Ferring Pharmaceuticals
23.10 Finch Therapeutics
23.11 Maat Pharma
23.12 Merck
23.13 Microbiome Therapeutics
23.14 Novartis
23.15 OpenBiome
23.16 Pfizer
23.17 Rebiotix
23.18 Second Genome
23.19 Seres Therapeutics
23.20 Symberix
23.21 Takeda Pharmaceuticals
23.22 Vedanta Bioscience

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/d6z6gb

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Global Human Microbiome Immunology Therapeutics Market & Clinical Trial Insights to 2025 - ResearchAndMarkets.com

Global Human Microbiome Immunology Therapeutics Market & Clinical Trial Insights to 2025 – ResearchAndMarkets.com

  • September 1, 2020

DUBLIN–()–The “Global Human Microbiome Immunology Therapeutics Market & Clinical Trial Insight 2025” clinical trials has been added to ResearchAndMarkets.com’s offering.

The scale and scope of microbiome research activity has now become one of the fastest growing areas in biology. The relevance that it has shown for the welfare of the society and pharmaceutical industry has led to the development of a transdisciplinary environment that is however conducive to innovation with a mission to abolish the limitations in the pharmaceutical industry through excellence in microbiome research, awareness and outreach. Over the years now, gut microbiome is estimated to implicate success for the various immunotherapies.

Microbiome’s role in immunology practices is to transform world-class treatment into the medicine of today and tomorrow. It is highly recognizable that the healthcare issues that mankind is facing today is now bigger than any one solution. The treatment of certain diseases requires multiple options for the treatment and ultimately prevention. Therefore, the amalgamation of two different treatment paradigms i.e. microbiome and immunology are apparently delivering some medical benefits that millions of patients were in need for long period of time. The ways in which microbiome is understood and manipulated to serve the immunological aspects has given great interest to all the researchers.

The essential and usual concept of immunology depicts targeting the immune system of the body to provoke an immune response with huge impact but then the unsuccessful implication of immunology therapies driven treatments led to an exploration of several other basic concepts that could play an important role in boosting the immune system when combined. Looking forward, the microbiome community in the gut represented beneficial patterns with respect to further research. The area of microbiome research and its combination with immunological aspect for the disease treatment has produced a real excitement in the area of medical research and specifically microbiome research.

Companies Mentioned

  • 4D Pharma
  • AbbVie
  • AstraZeneca plc
  • Biocodex
  • Bristol Mayer Squibb
  • Corebiome/Diversigen
  • Elogi Bioscience
  • Enterome
  • Ferring Pharmaceuticals
  • Finch Therapeutics
  • Maat Pharma
  • Merck
  • Microbiome Therapeutics
  • Novartis
  • OpenBiome
  • Pfizer
  • Rebiotix
  • Second Genome
  • Seres Therapeutics
  • Symberix
  • Takeda Pharmaceuticals
  • Vedanta Bioscience

Report Highlights:

  • Global & Regional Market Insight
  • Global Human Microbiome Immunology Therapeutics Market: >US$ 1 Billion by 2025
  • US Dominates Global Market Landscape: >60% Market Share
  • Comprehensive Information on Ongoing Clinical Trials & Potential Drug Candidates
  • Global Microbiome Modulator Drugs in Clinical Pipeline: >80 Drug in Trials
  • Therapeutic Applications of Microbiome Immunology by Indication
  • Clinical Trial Studies Related to Fecal Microbiota Transplant: > 250 Clinical Trials

Key Topics Covered:

1. Overview of Microbiome

2. Role of Microbiome in Human Body

3. Microbiome: Various Forms

4. Mechanism of Microbiome Activity

4.1 Nature of Immune Response

4.1.1 Immunosuppressive Activity

4.1.2 Immunostimulatory Activity

4.2 Messengers Involves in Microbiome Mechanism

4.2.1 MAMPs/PAMPs

4.2.2 Microbial Metabolites As Messengers

4.2.3 Host Cytokines As Messengers

4.2.4 Immune Cells As Messengers

5. Technological Requirement for Microbiota

5.1 Technologies Used

5.1.1 iChip

5.1.2 Simulator of the Human Intestinal Microbial Ecosystem (SHIME)

5.1.3 Gut-on-a-Chip System

5.1.4 Colonic Stem Cell Construction

5.2 Harnessing & Engineering the Microbiome

5.2.1 Additive Approaches

5.2.2 Subtractive Approaches

6. Need for Microbiome Immunology

7. Therapeutic Applications of Microbiome Immunology

7.1 Microbiome Therapy

7.2 Precision Medicine

7.3 Drug discovery

7.4 Biomarkers & Therapy Optimization

8. Human Microbiota in Infectious Diseases

8.1 Infection with Clostridium Difficile

8.2 Infection with Helicobacter Pylori

8.3 Bacterial Vaginosis

8.4 Infection with HIV

9. The Human Microbiota & Liver Diseases

9.1 Non-Alcoholic Fatty Liver Disease (NAFLD)

9.2 Alcoholic Liver Diseases (ALD)

9.3 Liver Fibrosis & Cirrhosis

10. The Human Microbiota & Metabolic Disorders

10.1 Obesity

10.2 Type 2 Diabetes

11. The Human Microbiota & Other Diseases

11.1 Microbiota & Allergic Diseases

11.2 Microbiota & Psychiatric Diseases

12. Microbiome in Immuno Oncology

12.1 Role of Microbiome in Immuno Oncology

12.2 Microbiome Mechanism in Oncogenesis & Tumor Suppression

13. Microbiome Application by Cancer Types

13.1 Gastric Cancer

13.2 Colorectal Cancer

13.3 Esophageal Cancer

13.4 Hepatocellular Carcinoma

13.5 Melanoma

13.6 Solid Tumors

14. Industrial Approaches of Microbiome Therapy in Oncology

14.1 Bacterial Approaches

14.1.1 Fecal Microbiota Transplantation (FMT)

14.1.2 Synthetic Bacteria

14.1.3 Microbial Culture

14.2 Microbiome as Vaccine

14.3 Microbiome as Small Molecules

14.4 Microbiome Therapy using Phage Virus

15. Global Human Microbiome Market Analysis

15.1 Overview

15.2 Human Microbiome Market Segmentation

15.2.1 Regional Segmentation

15.2.2 Disease Based Segmentation

15.2.3 Segmentation by Application

16. Clinical Pipeline of Microbiome Based Therapy

16.1 Microbiome Modulators in Clinical Trial

16.2 Cancer Related Clinical Trials

16.2.1 Preclinical & Discovery Phase

16.2.2 Active Clinical Trials

16.3 Clinical Trial Related To FMT

16.3.1 Clinical Trial for Recurrent C. difficile

16.3.2 Clinical Trial for Inflammatory Bowel Disease (IBD)

16.3.3 Other FMT Related Clinical Trials

17. Global Microbiome Modulators Clinical Pipeline By Company, Indication & Phase

17.1 Research

17.2 Preclinical

17.3 Clinical

17.4 Phase-I

17.5 Phase-I/II

17.6 Phase-II

17.7 Phase-II/III

17.8 Phase-III

18. Marketed Microbiome Modulators Clinical Insight

18.1 Sodium Oligomannurarate – Shanghai Green Valley Pharmaceutical

18.2 Miya-BM

19. Global Microbiome Immunology Therapeutics Market Growth Drivers

20. Microbiome Technology – Investments, Acquisitions & Collaborations by Leading Microbiome Companies

21. Blockades in the Microbiome Immunology Market

21.1 Stable Engraftment

21.2 Development of Clinically Relevant Sensors

21.3 Robustness and Evolutionary Stability of Genetic Circuits

21.4 Regulation, Safety and Biocontainment

22. Global Microbiome Immunology Market Future Panorama

23. Competitive Landscape

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/sk8m3s

Global Human Microbiome Immunology Therapeutics Market & Clinical Trial Insight 2025

Global Human Microbiome Immunology Therapeutics Market & Clinical Trial Insight 2025

  • September 1, 2020

New York, Sept. 01, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Human Microbiome Immunology Therapeutics Market & Clinical Trial Insight 2025” – https://www.reportlinker.com/p05955078/?utm_source=GNW
• US Dominates Global Market Landscape: >60% Market Share
• Comprehensive Information on Ongoing Clinical Trials & Potential Drug Candidates
• Global Microbiome Modulator Drugs in Clinical Pipeline: >80 Drug in Trials
• Therapeutic Applications of Microbiome Immunology by Indication
• Clinical Trial Studies Related to Fecal Microbiota Transplant: > 250 Clinical Trials

The scale and scope of microbiome research activity has now become one of the fastest growing areas in biology. The relevance that it has shown for the welfare of the society and pharmaceutical industry has led to the development of a transdisciplinary environment that is however conducive to innovation with a mission to abolish the limitations in the pharmaceutical industry through excellence in microbiome research, awareness and outreach. Over the years now, gut microbiome is estimated to implicate success for the various immunotherapies. 

Microbiome’s role in immunology practices is to transform the world-class treatment into the medicine of today and tomorrow. It is highly recognizable that the healthcare issues that mankind is facing today is now bigger than any one solution. The treatment of certain diseases requires multiple options for the treatment and ultimately prevention. Therefore, the amalgamation of two different treatment paradigms i.e. microbiome and immunology are apparently delivering some medical benefits that millions of patients were in need for long period of time. The ways in which microbiome is understood and manipulated to serve the immunological aspects has given great interest to all the researchers. 

Essential and usual concept of immunology depicts targeting the immune system of the body to provoke an immune response with huge impact but then unsuccessful implication of immunology therapies driven treatments led to exploration of several other basic concepts that could play an important role in boosting the immune system when combined. Looking forward, the microbiome community in the gut represented beneficial patterns with respect to further research. The area of microbiome research and its combination with immunological aspect for the disease treatment has produced a real excitement in the area of medical research and specifically microbiome research. 

All over the world, the amalgamation of the two has been well accepted and appreciated by the patients, physicians and the clinicians. Investigation of all the working sides of microbiome and how it plays an important role in boosting the manipulated immune cells have recently started in large numbers as the technology available in the medical field allows to capture it accurately. To facilitate the microbiome and immunology community in order to extract the best and trending opportunities that are stemmed into the microbiome research, the experts from both the relevant disciplines are analyzing it through clinical researches and surveys. Further, the area is getting supported by 86 different clinical trials getting conducted in different countries. 

“Global Human Microbiome Immunology Therapeutics Market & Clinical Trial Insight 2025” report summarizes the view of the wider opportunities that are associated microbiome community for the advancement of the scientific information regarding immunology. The science that is related with microbiome has high interdisciplinary and various opportunities that somehow have remained hidden in the medical world. It is believed that the opportunities and all the desirable tangible benefits microbiome is capable of delivering when combined with immunology is large and needs coordinated and constructive approach. The call to the two different sectors i.e. microbiology and immunology is estimated to unlock the potential and promising benefits of microbiome. The approach leading to the extraction of advantages if properly embedded in the microbiome and immunology research, the future benefits will be huge

Read the full report: https://www.reportlinker.com/p05955078/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Food nucleotides Market with Covid-19 Impact Analysis, Growth Opportunities, Analysis and Forecasts Report 2020-2027 – The Daily Chronicle

Food nucleotides Market with Covid-19 Impact Analysis, Growth Opportunities, Analysis and Forecasts Report 2020-2027 – The Daily Chronicle

  • August 31, 2020

Food nucleotides market is expected to reach USD 657.9 Million by 2027 growing at a growth rate of 4.0% in the forecast period 2020 to 2027. Increasing consumption of food nucleotides to boost the immune system will act as a factor for the food nucleotides market in the forecast period of 2020- 2027.

Food nucleotides Market analysis report has studied key opportunities in the market and influencing factors which is useful to take business to the new level. Moreover, competitive analysis gives an obvious idea about the strategies used by the major competitors in the Food nucleotides market which perks up their penetration in the market. This market report is an excellent resource that provides current as well as upcoming technical and financial details of the industry to 2026. The rise in market value is generally attributed to the rising growth of the applicable industries and the subsequent rise in demand of applications.

The Food nucleotides market document identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the market. This Food nucleotides market report performs comprehensive analysis of profiles of key market players that gives a competitive landscape to the businesses. Besides this, market drivers, market restraints, opportunities and challenges are evaluated under market overview which gives valuable insights to businesses for taking right moves. The report comprises of precise and up to date information about the consumer’s demands, their preferences, and their variable likings about particular product. No stone is left unturned about the market research analysis while generating and presenting this Food nucleotides market research report to the clients which satisfies their anticipation.

 Ask for Sample Copy of This Report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-food-nucleotides-market   

The major players covered in the food nucleotides report are Ohly, Agilent Technologies, Inc, Promega Corporation., Biorigin, MEIHUA HOLDINGS GROUP CO., LTD, STAR LAKE BIOSCIENCE., Lallemand Inc., Thermo Fisher Scientific Inc., DSM, CJ CHEILJEDANG CORP., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analyst understands competitive strengths and provides competitive analysis for each competitor separately.

 

(***Our Free Sample Copy of the report gives a brief introduction to the research report outlook, TOC, list of tables and figures, an outlook to key players of the market and comprising key regions.***)

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Global Food nucleotides Market which would mention How the Covid-19 is affecting the Industry, Food nucleotides Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for the Global Food nucleotides Market Players to Combat Covid-19 Impact.

Key Market Features in Global (United States, European Union and China) Food nucleotides Market:

The report highlights Food nucleotides market features, including revenue, weighted average regional price, capacity utilization rate, production rate, gross margins, consumption, import & export, supply & demand, cost bench-marking, market share, CAGR, and gross margin.

Analytical Food nucleotides Market Highlights & Approach

The Global (United States, European Union and China) Food nucleotides Market report provides the rigorously studied and evaluated data of the top industry players and their scope in the market by means of several analytical tools. The analytical tools such as Porters five forces analysis, feasibility study, SWOT analysis, and ROI analysis have been practiced reviewing the growth of the key players operating in the market.

 And More…..Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-food-nucleotides-market

 

Key Regions and Countries Studied in this report:

Regions North America South & Central America Europe Asia Pacific Middle East & Africa
Countries United States Argentina United Kingdom China Saudi Arabia
  Canada Chile Germany Japan UAE
  Mexico Brazil France India Turkey
      Italy, Spain, NORDIC {Sweden, Norway, Finland, Denmark etc}, and Russia Australia, Singapore, Japan, South Korea Egypt and South Africa

 Region Included are: United States, Europe, China, Japan, Southeast Asia, India & Central & South America

Key Benefits:

  1. The report provides a qualitative and quantitative analysis of the current Food nucleotides market trends, forecasts, and market size to determine the prevailing opportunities.
  2. Porter’s Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make strategic business decisions and determine the level of competition in the industry.
  3. Top impacting factors & major investment pockets are highlighted in the research.
  4. The major countries in each region are analyzed and their revenue contribution is mentioned.
  5. The market report also provides an understanding of the current position of the market players active in the Food nucleotides industry.

(**NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.)

Key poles of the TOC:

Chapter 1 Global Food nucleotides Market Business Overview

Chapter 2 Major Breakdown by Type

Chapter 3 Major Application Wise Breakdown (Revenue & Volume)

Chapter 4 Manufacture Market Breakdown

Chapter 5 Sales & Estimates Food nucleotides Market Study

Chapter 6 Key Manufacturers Production and Sales Market Comparison Breakdown

…………………..

Chapter 8 Manufacturers, Deals and Closings Market Evaluation & Aggressiveness

Chapter 9 Key Companies Breakdown by Overall Market Size & Revenue by Type

…………………….

Chapter 11 Business / Industry Chain (Value & Supply Chain Analysis)

Chapter 12 Conclusions & Appendix

What Businesses Can Hope to Get in Business Intelligence on Food nucleotides Market?

The study insights on the Food nucleotides market growth dynamics and opportunities highlights various key aspects, in which crucial ones are:

Which are the technology and strategic areas that emerging, new entrants, and established players should focus on keep growing in the industry-wide disruptions that COVID-19 has caused?

Which new avenues bear incredible potential during the ongoing COVID-19 lockdown restrictions?

Which policies by governments can give the top stakeholders support their efforts of consolidation?

What new business models are gathering pace among companies to remain agile in post-COVID-era?

Which segments will see a surge in popularity in near future, and what calibrations players need to make to utilize the trend for an elongated period?

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

[email protected]

 

 

 

 

 

Do NOT follow this link or you will be banned from the site!